about
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.Fecal biomarkers in inflammatory bowel disease: how, when and why?Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease.The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group.Re: American Gastroenterological Association Institute Guideline on therapeutic drug monitoring in inflammatory bowel disease.Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Fecal biomarkers in inflammatory bowel disease.
@en
type
label
Fecal biomarkers in inflammatory bowel disease.
@en
prefLabel
Fecal biomarkers in inflammatory bowel disease.
@en
P2093
P2860
P921
P356
P1476
Fecal biomarkers in inflammatory bowel disease.
@en
P2093
Andrew S Day
Gilles Duvoisin
Robert N Lopez
Steven T Leach
P2860
P304
P356
10.1111/JGH.13611
P577
2016-10-10T00:00:00Z